Ruan et al., 2011 - Google Patents
Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain gliomaRuan et al., 2011
View PDF- Document ID
- 16860084839118594221
- Author
- Ruan Z
- Zhao Y
- Yan L
- Chen H
- Fan W
- Chen J
- Wu Q
- Qian J
- Zhang T
- Zhou K
- Mao Y
- Zhou L
- Huang Y
- Lu D
- Publication year
- Publication venue
- Front Biosci (Elite Ed)
External Links
Snippet
[Frontiers in Bioscience E3, 33-45, January 1, 2011] 33 Single nucleotide polymorphisms in
IL-4Ra,IL-13 and STAT6 genes occurs i Page 1 [Frontiers in Bioscience E3, 33-45, January 1,
2011] 33 Single nucleotide polymorphisms in IL-4Ra,IL-13 and STAT6 genes occurs in brain …
- 102000003816 Interleukin-13 0 title description 64
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Paradowska‐Gorycka et al. | Association between IL‐17F gene polymorphisms and susceptibility to and severity of Rheumatoid Arthritis (RA) | |
Kastbom et al. | Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project) | |
Kang et al. | The influence of a polymorphism at position− 857 of the tumour necrosis factor α gene on clinical response to etanercept therapy in rheumatoid arthritis | |
JimÊnez-Morales et al. | Tumor necrosis factor–α is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population | |
Perricone et al. | An overview on the genetic of rheumatoid arthritis: a never-ending story | |
Slager et al. | Genetics of asthma susceptibility and severity | |
Sekiguchi et al. | Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-α monoclonal antibody, infliximab | |
Wang et al. | IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis | |
Fischer et al. | A novel sarcoidosis risk locus for Europeans on chromosome 11q13. 1 | |
Li et al. | Genetic variant in IL33 is associated with susceptibility to rheumatoid arthritis | |
Nemec et al. | Polymorphism in the tumor necrosis factor-α gene promoter is associated with severity of rheumatoid arthritis in the Czech population | |
McPherson et al. | Inflammation and coronary artery disease: insights from genetic studies | |
Park et al. | Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE | |
Yang et al. | ELF1 is associated with systemic lupus erythematosus in Asian populations | |
Akkad et al. | Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients | |
Mohamed et al. | Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population | |
US20100092468A1 (en) | Method for predicting therapeutic responsiveness to tnf-alpha blocking agents | |
Ruan et al. | Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma | |
Yu et al. | Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch–Schönlein purpura susceptibility and severity | |
Liang et al. | Signal transducer and activator of transcription 4 gene polymorphisms associated with rheumatoid arthritis in Northwestern Chinese Han population | |
Namkung et al. | Association of single nucleotide polymorphisms in the IL-12 (IL-12A and B) and IL-12 receptor (IL-12Rβ1 and β2) genes and gene–gene interactions with atopic dermatitis in Koreans | |
Stuhlmüller et al. | Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns-A strategy to detect predictors of methotrexate response in early rheumatoid arthritis | |
Liu et al. | Association of GTF2I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a Chinese Han population | |
Hussein et al. | Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients | |
Vargas-Alarcón et al. | The interleukin-1β-511 T> C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients |